Adlai Nortye Raises $53M in Series B
HANGZHOU, China, July 5, 2018 /PRNewswire/ — Adlai Nortye Biopharma Co., Ltd. (“Adlai Nortye” or “the Company”), a biopharmaceutical company, announced that it has raised $53 million in a Series…
The Art & Science of Wellness
HANGZHOU, China, July 5, 2018 /PRNewswire/ — Adlai Nortye Biopharma Co., Ltd. (“Adlai Nortye” or “the Company”), a biopharmaceutical company, announced that it has raised $53 million in a Series…
HSINCHU and WUHAN, July 6, 2018 /PRNewswire/ — JHL Biotech announced today that the Center for Drug Evaluation (CDE), State Drug Administration of China (SDA) has approved JHL’s Phase I…
SHANGHAI, July 4, 2018 /PRNewswire/ — The 65th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) was recently held in Philadelphia, USA. SNMMI selected China as…
CHENGDU, China, July 4, 2018 /PRNewswire/ — Tianfu Software Park is one of the largest tech parks in China, we selected a batch of excellent enterprises which grown up in…
TAIPEI, Taiwan, July 4, 2018 /PRNewswire/ — Taiwan’s leading trade show featuring agriculture, aquaculture and livestock manufacturing technologies and total solutions, the Asia Agri-Tech Expo & Forum 2018 will take…
LONDON and NEW YORK, July 3, 2018 /PRNewswire/ — Smith & Nephew (LSE: SN) (NYSE: SNN), the global medical technology business, announces that the UK’s National Institute for Health and…
-Teachers and students exchange views on “Facing the World: The Role, Opportunities and Challenges of Promoting Sustainable Development in China” -Dr. Mo Yan, member of the Prize Recommendation Committee, and…
SHANGHAI, June 29, 2018 /PRNewswire/ — I-Mab Biopharma, a company focusing on innovative Biologics in therapeutic areas of immuno-oncology and immuno-inflammation, announced the completion of Series C financing for USD…
ZHUHAI, China, July 1, 2018 /PRNewswire/ — The 4th China-Israel Investment Summit will be held at the Zhuhai International Convention and Exhibition Center from July 2nd to 3rd. This summit…
Single-scan multi-contrast technology — allowing accurate examination of multiple sclerosis and other brain diseases, developed through close collaborations among United Imaging, Sungkyunkwan University (SKKU) and the PLA General Hospital (PGH).…
Multilingual WordPress with WPML